Here’s why we believe Globus Medical (GMED) stock merits attention as a value stock. It’s currently trading approximately 33% below its 1-year high and is also trading at a PS multiple that falls ...
AUDUBON, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced that Keith Pfeil, Executive Vice President, Chief ...
Feb 9 (Reuters) - Globus Medical Inc (GMED.N), opens new tab said on Thursday it would acquire peer NuVasive Inc (NUVA.O), opens new tab in an all-stock deal valued at about $3 billion to build scale ...
Medical device company Globus Medical (NYSE:GMED) announced better-than-expected revenue in Q3 CY2025, with sales up 22.9% year on year to $769 million. The company’s full-year revenue guidance of ...
Globus Medical stock was headed for its largest same-day percentage increase on record Friday, and analysts expect the gains to continue.
The Montgomery County company has FDA clearance for 11 orthopedic trauma products. Globus Medical Inc. is making a big push in the orthopedic trauma market. The Audobon, Pa., manufacturer of implants ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results